Procept Biorobotics
PRCT
242 hedge funds and large institutions have $2.06B invested in Procept Biorobotics in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 95 increasing their positions, 69 reducing their positions, and 62 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 69
7.59% more ownership
Funds ownership: 96.38% → 103.96% (+7.6%)
11% less funds holding
Funds holding: 271 → 242 (-29)
11% less call options, than puts
Call options by funds: $12.9M | Put options by funds: $14.5M
33% less capital invested
Capital invested by funds: $3.07B → $2.06B (-$1.01B)
40% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 62
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$57.7M |
| 2 |
CC
Chicago Capital
Chicago,
Illinois
|
+$45.7M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$35.9M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$34.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$24.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$49M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$21.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$17.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$15M |
PRCT Hedge Fund Activity: Q3 2025 in Review
242 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q3 2025, worth a combined $2.06B — down 33% from $3.07B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of PRCT and 37 opened new positions — a net loss of 25 holders — while 69 trimmed existing stakes and 95 added.
The largest buyer was AllianceBernstein, adding an estimated $57.7M. The largest seller was Axa, exiting entirely with an estimated $49M sold.
- 242 institutional investors held Procept Biorobotics (PRCT) as of Q3 2025, down from 271 in Q2 2025.
- Funds reported $2.06B of Procept Biorobotics stock for Q3 2025, down 33% quarter-over-quarter.
- 37 funds opened new Procept Biorobotics positions in Q3 2025 and 62 closed out, a net change of -25 holders.
- The largest Procept Biorobotics buyer in Q3 2025 was AllianceBernstein, an estimated $57.7M added.
- The largest Procept Biorobotics seller in Q3 2025 was Axa, an estimated $49M sold.
Based on aggregated 13F filings for Q3 2025.